Revenue
2018
2019
2020
2021
2022
2023
2024
2025
InspireMD, Inc. (NSPR)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M | $4.5M | $2.5M | $3.7M | $3.6M | $2.8M | $1.9M | $2.3M | $2.8M | $4.9M | $5.3M | $6.0M | $4.9M | $3.4M |
| Gross profit | $2.6M | $1.5M | $1.8M | $1.1M | $754,000 | $83,000 | $756,000 | $995,000 | $585,000 | $102,000 | −$296,000 | $784,000 | $2.6M | $2.5M | $3.0M | $2.3M | $1.1M |
| Research & development | $15.0M | $13.6M | $8.0M | $7.8M | $5.2M | $2.2M | $3.0M | $1.5M | $1.3M | $1.3M | $3.6M | $8.7M | $4.2M | $4.0M | $2.5M | $1.3M | $1.3M |
| Operating expenses | $52.3M | $35.0M | $22.9M | $19.8M | $15.5M | $10.5M | $10.6M | $8.6M | $8.8M | $7.8M | $14.2M | $24.5M | $17.7M | $20.0M | $16.7M | $5.5M | $3.8M |
| Operating income | −$49.6M | −$33.5M | −$21.1M | −$18.7M | −$14.7M | −$10.4M | −$9.8M | −$7.6M | −$8.2M | −$7.6M | −$14.5M | −$23.7M | −$15.1M | −$17.5M | −$13.7M | −$3.2M | −$2.7M |
| EBITDAderived | $426.4M | $246.5M | $210.9M | $169.3M | −$14.6M | −$10.2M | −$9.7M | −$7.5M | −$8.1M | −$7.5M | −$14.3M | −$23.4M | −$14.9M | −$17.4M | −$13.6M | −$3.1M | −$2.6M |
| Net income | −$48.8M | −$32.0M | −$19.9M | −$18.5M | −$14.9M | −$10.5M | −$10.0M | −$7.2M | −$8.4M | −$8.5M | −$15.6M | −$25.1M | −$29.3M | −$17.6M | −$14.7M | −$3.4M | −$2.7M |
| Basic EPSper diluted share | -$0.76 | -$0.76 | -$0.82 | -$2.35 | -$2.03 | -$6.97 | -$4.80 | -$16.67 | -$34.98 | -$207.72 | -$55.85 | -$7.09 | -$1.39 | -$1.04 | -$0.24 | -$0.07 | -$0.06 |
| Diluted EPSper diluted share | -$0.76 | -$0.76 | -$0.82 | -$2.35 | -$2.03 | -$6.97 | -$4.80 | -$16.67 | -$34.98 | -$207.72 | -$55.85 | -$7.09 | -$1.39 | -$1.04 | -$0.24 | -$0.07 | -$0.06 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 27, 2026Form 4 | Stuka PaulDirector | BuyCommon Stock | 20.0K | $0.88 | $17.6K | 667.9K |
| May 19, 2026Form 4 | Gleason Shane ThomasChief Commercial Officer | SellCommon Stock | 22.8K | $1.01 | $23.0K | 1.05M |
| May 14, 2026Form 4 | Stuka PaulDirector | BuyCommon Stock | 5.0K | $1.15 | $5.8K | 647.9K |
| May 13, 2026Form 4 | Stuka PaulDirector | BuyCommon Stock | 10.0K | $1.16 | $11.6K | 642.9K |
| May 12, 2026Form 4 | Slosman MarvinCEO and President | BuyCommon Stock | 21.0K | $1.20 | $25.2K | 3.56M |